Comment on «Subclinical atrial fibrillation and the risk of stroke»

Comment on «Subclinical atrial fibrillation and the risk of stroke»

Bibliographic Details
Main Author:	Diogo Magalhães Cavaco
Format:	Article
Language:	English
Published:	Elsevier 2012-05-01
Series:	Revista Portuguesa de Cardiologia (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S217420491200075X

Similar Items

Subclinical atrial fibrillation - what is the risk of stroke?
by: Jiri Plasek, et al.
Published: (2019-06-01)

Comment on “Surgical ablation of atrial fibrillation during mitral‐valve surgery”
by: Diogo Magalhães Cavaco
Published: (2016-04-01)

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
by: Ahmed AlTurki, et al.
Published: (2019-09-01)

Epidemiology of atrial fibrillation in Galicia: Insights from ‘big data’
by: Diogo Magalhães Cavaco
Published: (2019-01-01)

Epidemiology of atrial fibrillation in Galicia: Insights from ‘big data’
by: Diogo Magalhães Cavaco
Published: (2019-01-01)

Comment on “Stroke Prevention in Atrial Fibrillation: A Systematic Review”
by: Evangelista Rocha
Published: (2015-07-01)

Comment on «Stroke and bleeding in atrial fibrillation with chronic kidney disease»
by: Carlos Aguiar
Published: (2012-12-01)

Approach to device-detected subclinical atrial fibrillation
by: van Zyl, Martin, et al.
Published: (2017-08-01)

A pharmacotherapy of atrial fibrillation in subclinical thyrotoxicosis
by: R.F. Rakhmatullov, et al.
Published: (2021-09-01)

Comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting”
by: Luís Silva Miguel
Published: (2015-11-01)

Atrial fibrillation and its influence on stroke risk
by: Prisco D, et al.
Published: (2015-02-01)

The risk factors and prevention of stroke in atrial fibrillation
by: V. A. Parfenov, et al.
Published: (2014-10-01)

The Impact of Hypertension and Atrial Fibrillation on Cognitive Decline and Subclinical Atherosclerosis
by: Marius Militaru, et al.
Published: (2021-06-01)

Reply to the comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting”
by: João Morais
Published: (2015-11-01)

Atrial fibrillation and silent stroke: links, risks, and challenges
by: Hahne K, et al.
Published: (2016-03-01)

Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality
by: Giovanni Luca Botto, et al.
Published: (2021-07-01)

THE OPPORTUNITIES FOR RISK REDUCTION OF RECURRENT STROKE IN ATRIAL FIBRILLATION
by: I. L. Davydkin, et al.
Published: (2015-06-01)

Risk of ischemic stroke in patients with atrial fibrillation in Taiwan
by: Tze-Fan Chao, et al.
Published: (2015)

Stroke prevention in atrial fibrillation
by: C, et al.
Published: (2017-03-01)

Stroke prevention in atrial fibrillation
by: Själander, Sara
Published: (2016)

Stroke, Dementia and Atrial Fibrillation
Published: (2020)

Increased left atrial pressure in non-heart failure patients with subclinical hypothyroidism and atrial fibrillation
by: Akinori Sairaku, et al.
Published: (2016-05-01)

GWAS contribution to Atrial Fibrillation and Atrial Fibrillation-related Stroke: pathophysiological implications
by: Diana Vanessa Marques Cruz
Published: (2019)

The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
by: Trevor Mace-Brickman, et al.
Published: (2019-12-01)

Stroke in atrial fibrillation: Review of risk stratification and preventive therapy
by: Abdullah M Alshehri
Published: (2019-01-01)

Atrial Fibrillation and Stroke in Elderly Patients
by: Geetanjali Dang, et al.
Published: (2016-11-01)

Stroke as the First Manifestation of Atrial Fibrillation.
by: Jussi Jaakkola, et al.
Published: (2016-01-01)

Paroxysmal atrial fibrillation in cryptogenic stroke
by: Neha S Dangayach, et al.
Published: (2011-01-01)

Stroke and atrial fibrillation in hypertrophic cardiomyopathy
by: Guttmann, O. P.
Published: (2015)

Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice
by: Andrea Ballatore, et al.
Published: (2019-08-01)

Comparison of left atrial and left atrial appendage mechanics in the risk stratification of stroke in patients with atrial fibrillation
by: Yankai Mao, et al.
Published: (2021-01-01)

Silent ischemic brain lesions detected by multi-slice computed tomography are associated with subclinical atrial fibrillation in patients with cardiac resynchronization therapy with subclinical atrial fibrillation in patients with cardiac resynchronization therapy
by: Yahya Kemal İçen, et al.
Published: (2018-09-01)

Comment on “Disease management: Atrial fibrillation and home monitoring”
by: Daniel Ferreira
Published: (2014-07-01)

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
by: Sébastien Champion
Published: (2015-01-01)

Comment on “Management of Atrial Fibrillation in Critically Ill Patients”
by: Roger Jelliffe
Published: (2016-01-01)

Stroke risk stratification in atrial fibrillation: a review of common risk factors
by: Oreoluwa Oladiran, et al.
Published: (2019-03-01)

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
by: Taral K. Patel, et al.
Published: (2012-01-01)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
by: Yihong Sun, et al.
Published: (2019-01-01)

Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation.
by: Michael P Lerario, et al.
Published: (2015-01-01)

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
by: Wern Yew Ding, et al.
Published: (2020-02-01)